Production and distribution of active pharmaceutical ingredients (APIs) for healthcare professionals.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
Evaluation in progress...
This analysis is not yet available in English. Please see the French version.
Leading organizations
CordenPharma
B
Development and manufacturing of active pharmaceutical ingredients (APIs), drug products, and lipid excipients for the pharmaceutical industry.
Minakem
B
Development and production of active pharmaceutical ingredients (APIs) and highly active pharmaceutical ingredients (HAPIs) for cancer treatments.
Octapharma France
B
Development and distribution of therapeutic pharmaceutical products for healthcare professionals and patients.
Initiatives identified among leaders
Audits réguliers pour évaluer et améliorer la sécurité et l'environnement
“Minakem réalise régulièrement des audits en matièr...” - MinakemPrévention des accidents et des maladies professionnelles
“CordenPharma met en place des mesures pour préveni...” - CordenPharmaEngagement RSE structuré selon normes internationales pour intégrité et pérennité
“Octapharma s’engage à intégrer une démarche de res...” - Octapharma France66% of similar organizations communicate on CSR issues
+1783 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports